(FFN) Ciencias Farmacéuticas

2024

1. 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

   ESMO Open, Vol. 9, Núm. 2

2. 2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential

   Supportive Care in Cancer, Vol. 32, Núm. 1

3. Biomaterials-Based Antioxidant Strategies for the Treatment of Oxidative Stress Diseases

   Biomimetics, Vol. 9, Núm. 1

4. Biosafety evaluation of etoposide lipid nanomedicines in C. elegans

   Drug Delivery and Translational Research

5. Correction to: Biosafety evaluation of etoposide lipid nanomedicines in C. elegans (Drug Delivery and Translational Research, (2024), 10.1007/s13346-023-01466-w)

   Drug Delivery and Translational Research

6. Essential Role of Astrocytes in Learning and Memory

   International Journal of Molecular Sciences, Vol. 25, Núm. 3

7. Feasibility of steroid-free tacrolimus-basiliximab immunosuppression in pediatric liver transplantation and predictors for steroid requirement

   Liver Transplantation, Vol. 30, Núm. 1, pp. 61-71

8. Fifty years of sciences with Patrick Couvreur: A tribute to Professor Patrick Couvreur: a creative and visionary scientist in the field of nanomedicine

   Drug Delivery and Translational Research

9. Formulation Studies with Cyclodextrins for Novel Selenium NSAID Derivatives

   International Journal of Molecular Sciences, Vol. 25, Núm. 3

10. Further development of CometChip technology to measure DNA damage in vitro and in vivo: Comparison with the 2 gels/slide format of the standard and enzyme-modified comet assay

    Toxicology, Vol. 501

11. Hazard characterization of Alternaria toxins to identify data gaps and improve risk assessment for human health

    Archives of Toxicology, Vol. 98, Núm. 2, pp. 425-469

12. High-Performance Liquid Chromatography–Fluorescence Detection Method for Ochratoxin A Quantification in Small Mice Sample Volumes: Versatile Application across Diverse Matrices Relevant for Neurodegeneration Research

    Toxins, Vol. 16, Núm. 5

13. How to use meropenem in pediatric patients undergoing CKRT? Integrated meropenem pharmacokinetic model for critically ill children

    Antimicrobial Agents and Chemotherapy, Vol. 68, Núm. 6

14. In memory of Dr. Ir. Gudrun Koppen (1969–2024)

    Mutation Research - Genetic Toxicology and Environmental Mutagenesis

15. Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy?

    Blood Advances

16. Mechanism-Based Modeling of Perioperative Variations in Hemoglobin Concentration in Patients Undergoing Laparoscopic Surgery

    Anesthesia and Analgesia, Vol. 138, Núm. 1, pp. 141-151

17. Model-Based Assessment of the Liver Safety Profile of Acetaminophen to Support its Combination Use with Topical Diclofenac in Mild-to-Moderate Osteoarthritis Pain

    Pain and Therapy, Vol. 13, Núm. 1, pp. 127-143

18. Model-Based Bioequivalence Analysis to Assess and Predict the Relative Bioavailability of Valproic Acid Formulations

    European Journal of Drug Metabolism and Pharmacokinetics

19. Model-Based Meta-Analysis Supporting the Combination of Acetaminophen and Topical Diclofenac in Acute Pain: A Therapy for Mild-to-Moderate Osteoarthritis Pain?

    Pain and Therapy, Vol. 13, Núm. 1, pp. 145-159

20. Monitoring Mycotoxin Exposure in Food-Producing Animals (Cattle, Pig, Poultry, and Sheep)

    Toxins, Vol. 16, Núm. 5